186 related articles for article (PubMed ID: 32947483)
1. Andersen-Tawil Syndrome: A Comprehensive Review.
Pérez-Riera AR; Barbosa-Barros R; Samesina N; Pastore CA; Scanavacca M; Daminello-Raimundo R; de Abreu LC; Nikus K; Brugada P
Cardiol Rev; 2021 Jul-Aug 01; 29(4):165-177. PubMed ID: 32947483
[TBL] [Abstract][Full Text] [Related]
2. Electrocardiogram in Andersen-Tawil syndrome. New electrocardiographic criteria for diagnosis of type-1 Andersen-Tawil syndrome.
Kukla P; Biernacka EK; Baranchuk A; Jastrzebski M; Jagodzinska M
Curr Cardiol Rev; 2014 Aug; 10(3):222-8. PubMed ID: 24827800
[TBL] [Abstract][Full Text] [Related]
3. Genotype-phenotype correlations of KCNJ2 mutations in Japanese patients with Andersen-Tawil syndrome.
Haruna Y; Kobori A; Makiyama T; Yoshida H; Akao M; Doi T; Tsuji K; Ono S; Nishio Y; Shimizu W; Inoue T; Murakami T; Tsuboi N; Yamanouchi H; Ushinohama H; Nakamura Y; Yoshinaga M; Horigome H; Aizawa Y; Kita T; Horie M
Hum Mutat; 2007 Feb; 28(2):208. PubMed ID: 17221872
[TBL] [Abstract][Full Text] [Related]
4. Andersen-Tawil syndrome: clinical and molecular aspects.
Nguyen HL; Pieper GH; Wilders R
Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
[TBL] [Abstract][Full Text] [Related]
5. Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.
Fernlund E; Lundin C; Hertervig E; Kongstad O; Alders M; Platonov P
Ann Noninvasive Electrocardiol; 2013 Sep; 18(5):471-8. PubMed ID: 24047492
[TBL] [Abstract][Full Text] [Related]
6. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1.
Kokunai Y; Nakata T; Furuta M; Sakata S; Kimura H; Aiba T; Yoshinaga M; Osaki Y; Nakamori M; Itoh H; Sato T; Kubota T; Kadota K; Shindo K; Mochizuki H; Shimizu W; Horie M; Okamura Y; Ohno K; Takahashi MP
Neurology; 2014 Mar; 82(12):1058-64. PubMed ID: 24574546
[TBL] [Abstract][Full Text] [Related]
7. Phenotype variability in patients carrying KCNJ2 mutations.
Kimura H; Zhou J; Kawamura M; Itoh H; Mizusawa Y; Ding WG; Wu J; Ohno S; Makiyama T; Miyamoto A; Naiki N; Wang Q; Xie Y; Suzuki T; Tateno S; Nakamura Y; Zang WJ; Ito M; Matsuura H; Horie M
Circ Cardiovasc Genet; 2012 Jun; 5(3):344-53. PubMed ID: 22589293
[TBL] [Abstract][Full Text] [Related]
8. Kir 2.1 channelopathies: the Andersen-Tawil syndrome.
Tristani-Firouzi M; Etheridge SP
Pflugers Arch; 2010 Jul; 460(2):289-94. PubMed ID: 20306271
[TBL] [Abstract][Full Text] [Related]
9. [Molecular genetic diagnostics of the cause of ventricular arrhythmias in children].
Brøndberg AK; Bjerre JV; Nielsen JC; Jensen HK
Ugeskr Laeger; 2015 Sep; 177(38):V04150366. PubMed ID: 26376421
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study.
Sung RJ; Wu SN; Wu JS; Chang HD; Luo CH
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2597-605. PubMed ID: 16877549
[TBL] [Abstract][Full Text] [Related]
11. [QTU pattern in a patient with the Anderson-Tawil syndrome].
Ciurzyński M; Bienias P; Kostera-Pruszczyk A; Pruszczyk P
Kardiol Pol; 2010 Mar; 68(3):339-41; discussion 342. PubMed ID: 20411461
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of a double-point mutation in the KCNJ2 gene identified in a family with Andersen-Tawil syndrome.
Fukumura S; Yamauchi K; Kawanabe A; Yamamoto A; Nakaza M; Kubota T; Kato S; Sasaki R; Okamura Y; Takahashi MP
J Neurol Sci; 2019 Dec; 407():116521. PubMed ID: 31669729
[TBL] [Abstract][Full Text] [Related]
13. Biophysical and molecular characterization of a novel de novo KCNJ2 mutation associated with Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia mimicry.
Barajas-Martinez H; Hu D; Ontiveros G; Caceres G; Desai M; Burashnikov E; Scaglione J; Antzelevitch C
Circ Cardiovasc Genet; 2011 Feb; 4(1):51-7. PubMed ID: 21148745
[TBL] [Abstract][Full Text] [Related]
14. Functional and clinical characterization of a mutation in KCNJ2 associated with Andersen-Tawil syndrome.
Lu CW; Lin JH; Rajawat YS; Jerng H; Rami TG; Sanchez X; DeFreitas G; Carabello B; DeMayo F; Kearney DL; Miller G; Li H; Pfaffinger PJ; Bowles NE; Khoury DS; Towbin JA
J Med Genet; 2006 Aug; 43(8):653-9. PubMed ID: 16571646
[TBL] [Abstract][Full Text] [Related]
15. Cardiac characteristics and long-term outcome in Andersen-Tawil syndrome patients related to KCNJ2 mutation.
Delannoy E; Sacher F; Maury P; Mabo P; Mansourati J; Magnin I; Camous JP; Tournant G; Rendu E; Kyndt F; Haïssaguerre M; Bézieau S; Guyomarch B; Le Marec H; Fressart V; Denjoy I; Probst V
Europace; 2013 Dec; 15(12):1805-11. PubMed ID: 23867365
[TBL] [Abstract][Full Text] [Related]
16. Mosaic KCNJ2 mutation in Andersen-Tawil syndrome: targeted deep sequencing is useful for the detection of mosaicism.
Hasegawa K; Ohno S; Kimura H; Itoh H; Makiyama T; Yoshida Y; Horie M
Clin Genet; 2015 Mar; 87(3):279-83. PubMed ID: 24635491
[TBL] [Abstract][Full Text] [Related]
17. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2.
Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G
Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118
[TBL] [Abstract][Full Text] [Related]
18. Clinical and neurophysiological variability in Andersen-Tawil syndrome.
Kokubun N; Aoki R; Nagashima T; Komagamine T; Kuroda Y; Horie M; Hirata K
Muscle Nerve; 2019 Dec; 60(6):752-757. PubMed ID: 31509255
[TBL] [Abstract][Full Text] [Related]
19. [A new type of periodic paralysis: Andersen-Tawil syndrome].
Pouget J
Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
